Teleflex (NYSE:TFX) is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions. Its portfolio features vascular access catheters and needle products, ureteral and stone management systems, airway management and respiratory care devices, laparoscopic instruments, hemostasis products and surgical stapling technologies. Teleflex also partners with other device manufacturers to supply custom components and subassemblies.
Founded in 1943, Teleflex originally operated in the industrial cable market before shifting its focus to the healthcare sector through strategic acquisitions and internal development. A landmark transaction in 2010 was the acquisition of Arrow International, which significantly expanded its presence in vascular access and interventional care. Today, Teleflex maintains manufacturing and research facilities across North America, Europe, Asia and Latin America and serves patients in more than 150 countries.
The company is led by President and Chief Executive Officer Benson Smith, supported by an executive team responsible for global operations, research and development, and regulatory affairs. Teleflex continues to invest in innovation and partnerships to address emerging clinical needs and enhance procedural efficiency for physicians and care teams worldwide.
